The National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase II to further develop sialic acid Lectenz®.
Lectenz Bio receives NIH SBIR Phase II
Category: Lectenz Bio News
Date: January 15, 2018
Author: lectenz® Bio